デフォルト表紙
市場調査レポート
商品コード
1603434

受胎能試験の市場規模、シェア、成長分析、製品別、購入形態別、用途別、エンドユーザー別、地域別 - 産業予測、2024年~2031年

Fertility Test Market Size, Share, Growth Analysis, By Product (Ovulation Predictor Kits, Fertility Monitors), By Mode of Purchase (OTC, Prescription), By Application, By End User, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
受胎能試験の市場規模、シェア、成長分析、製品別、購入形態別、用途別、エンドユーザー別、地域別 - 産業予測、2024年~2031年
出版日: 2024年11月26日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

受胎能試験の世界市場規模は、2022年に4億2,695万米ドルと評価され、2023年の4億6,324万米ドルから2031年には8億8,970万米ドルに成長し、予測期間(2024-2031年)のCAGRは8.5%で成長する見通しです。

受胎能試験市場は、いくつかの重要な要因に後押しされ、今後の予測期間において大きく成長する見込みです。特に、初回の妊娠を先延ばしにする動向や、不妊に対する意識の世界の高まりが、受胎能試験ソリューションの需要を促進しています。さらに、世界の出生率の低下と、高い精度を誇る革新的でユーザーフレンドリーな不妊治療モニターのイントロダクションが、市場拡大の主な要因となっています。特に先進国では、妊娠と排卵の両方に対応する複合検査キットの台頭が、市場の成長をさらに刺激すると予想されます。ヘルスケア・インフラ投資の強化も、高度な受胎能試験製品の普及を支え、消費者にとってより身近なものとなっています。しかし、PCOS/PCODのような疾患を持つ女性にとって尿をベースとした排卵モニターの信頼性が一定していないことや、これらの検査を受けるための費用が高額であることなどが課題として残っており、潜在的な購買意欲を減退させる可能性があります。全体として、受胎能試験市場は人口動態の動向と技術の進歩によって有望な成長の可能性を示しているが、精度の懸念とコスト関連の障壁に対処することは、市場への浸透を最大化し、こうした不可欠な健康製品に対する消費者の信頼を醸成する上で極めて重要です。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析と影響
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 技術の進歩
  • 規制情勢
  • バリューチェーン分析
  • ケーススタディ分析
  • 顧客と購買基準の分析
  • PESTEL分析
  • マクロ経済指標
  • 市場の魅力指数
  • 価格分析

受胎能試験の市場規模:製品別& CAGR(2024-2031)

  • 市場概要
  • 排卵予測キット
  • 妊娠モニター
  • 男性受胎能試験製品

受胎能試験の市場規模:購入方法別& CAGR(2024-2031)

  • 市場概要
  • OTCベースの製品
  • 処方箋ベースの製品
  • オンライン製品

受胎能試験の市場規模:用途別& CAGR(2024-2031)

  • 市場概要
  • 女性用受胎能製品
  • 男性用受胎能製品

受胎能試験の市場規模:エンドユーザー別& CAGR(2024-2031)

  • 市場概要
  • 在宅ケア環境
  • 病院と不妊治療クリニック
  • その他のエンドユーザー

受胎能試験の市場規模:地域別& CAGR(2024-2031)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東およびアフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2021-2023)

主要企業プロファイル

  • Church & Dwight Co., Inc.
  • Fairhaven Health LLC
  • Fertility Focus Limited
  • Geratherm Medical AG
  • HiLin Life Products Inc.
  • Prestige Brands Holdings Inc.
  • Quidel Corporation
  • Swiss Precision Diagnostics GmbH
  • AdvaCare Pharma
  • Babystart
  • BioZhena Corporation
  • Procter & Gamble Company
  • Uebe Medical GmbH
  • Samplytics Technologies Private Limited
  • Tempdrop LLC
  • Valley Electronics GmbH
  • PREGMATE
  • Ava Science Inc.
  • Alere Inc.
  • Abbot Laboratories

結論と推奨事項

目次
Product Code: SQMIG45A2234

Global Fertility Test Market size was valued at USD 426.95 million in 2022 and is poised to grow from USD 463.24 million in 2023 to USD 889.7 million by 2031, growing at a CAGR of 8.5% during the forecast period (2024-2031).

The fertility test market is poised for significant growth in the upcoming forecast period, propelled by several key factors. Notably, the trend of postponing first pregnancies and an increasing global emphasis on fertility awareness are driving demand for fertility testing solutions. Additionally, declining fertility rates worldwide, combined with the introduction of innovative, user-friendly fertility monitors that boast high accuracy, are key contributors to the market's expansion. The rise of combined testing kits that address both pregnancy and ovulation-particularly in developed countries-is expected to further stimulate market growth. Enhanced healthcare infrastructure investments are also supporting the proliferation of advanced fertility testing products, making them more accessible to consumers. However, challenges remain, including the inconsistent reliability of urine-based ovulation monitors for women with conditions such as PCOS/PCOD, as well as the high costs associated with acquiring these tests, which may deter potential buyers. Overall, while the fertility test market shows promising growth potential driven by demographic trends and technological advancements, addressing accuracy concerns and cost-related barriers will be crucial for maximizing market penetration and fostering consumer trust in these essential health products.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fertility Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fertility Test Market Segmental Analysis

Global Fertility Test Market is segmented by Product, Mode of Purchase, Application, End User and region. Based on Product, the market is segmented into Ovulation Predictor Kits, Fertility Monitors (Urine, Saliva, Blood), Male Fertility Testing Products. Based on Mode of Purchase, the market is segmented into OTC based products, Prescription based products, Online products. Based on application, the market is segmented into Female Fertility Products, Male Fertility Products. Based on end user, the market is segmented into home care, Fertility clinics, hospitals, others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Fertility Test Market

The Global Fertility Test market is significantly influenced by the increasing focus on reproductive health, particularly highlighted by the changing demographics of first-time pregnancies. There has been a noteworthy rise in the average age at which women are having their first child, with many women now waiting until 30 or older, as reported by the OECD. This trend has emerged due to a decline in teenage births and reflects a growing preference among women to postpone parenthood. Consequently, the heightened occurrence of first pregnancies among older women is driving demand for fertility-related products and services, propelling the expansion of the market.

Restraints in the Global Fertility Test Market

One significant restraint in the Global Fertility Test market is the limited precision of ovulation prediction kits. These kits function by measuring increases in luteinizing hormone (LH) levels, which typically spike 24-36 hours before ovulation. However, they fall short in reliably confirming ovulation in certain conditions, such as luteinized unruptured follicle syndrome, where the egg remains with the follicle post-LH surge. Additionally, these kits only indicate the onset of ovulation rather than pinpointing the exact timing or accounting for anovulation. The reliance solely on LH detection means they overlook other important markers like fertile cervical mucus, potentially hindering market growth due to their limited accuracy.

Market Trends of the Global Fertility Test Market

The Global Fertility Test market is witnessing a notable trend characterized by the rapid integration of digital health technologies, particularly through the use of smartphones and wearable devices. Fertility tracking apps and advanced ovulation monitors are enabling consumers to monitor their menstrual cycles and fertility metrics with unprecedented convenience. This shift toward digital solutions is transforming traditional fertility testing methodologies, offering users real-time data and personalized insights that foster proactive family planning. As individuals seek more accessible and informed approaches to reproductive health, this trend is likely to drive significant growth in the fertility test market, enhancing user engagement and confidence in their fertility journeys.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Value Chain Analysis
  • Case Study Analysis
  • Customer & Buying Criteria Analysis
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Market Attractiveness Index
  • Pricing Analysis

Global Fertility Test Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Ovulation Prediction Kits
  • Fertility Monitors
  • Male Fertility Testing Products

Global Fertility Test Market Size by Mode of Purchase & CAGR (2024-2031)

  • Market Overview
  • OTC-based products
  • Prescription-based products
  • Online Products

Global Fertility Test Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Female Fertility Products
  • Male Fertility Products

Global Fertility Test Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Home Care Settings
  • Hospitals and Fertility Clinics
  • Other End Users

Global Fertility Test Market Size & CAGR (2024-2031)

  • North America, (Product, Mode of Purchase, Application, End User)
    • US
    • Canada
  • Europe, (Product, Mode of Purchase, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product, Mode of Purchase, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product, Mode of Purchase, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product, Mode of Purchase, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Church & Dwight Co., Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fairhaven Health LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fertility Focus Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Geratherm Medical AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HiLin Life Products Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prestige Brands Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quidel Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Swiss Precision Diagnostics GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AdvaCare Pharma
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Babystart
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioZhena Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Procter & Gamble Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Uebe Medical GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Samplytics Technologies Private Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tempdrop LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Valley Electronics GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PREGMATE
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ava Science Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alere Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbot Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation